Not Enough Dentistry
JAMA Otolaryngology–Head & Neck Surgery,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 23, 2025
This
Viewpoint
discusses
the
gap
in
dental
insurance
coverage
for
patients
with
head
and
neck
cancer,
many
of
whom
forego
care
to
treat
or
prevent
oral
complications
cancer
therapy
due
financial
hardship.
Язык: Английский
2024 ASCO guidelines for the prevention and management of osteoradionecrosis in patients with head & neck cancer treated with radiation therapy
Current Opinion in Oncology,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 20, 2025
Purpose
of
review
Osteoradionecrosis
may
often
be
prevented
in
context
interprofessional
healthcare
that
includes
dental
specialists
prior
to
and
following
completion
the
patient's
head
neck
radiation
therapy.
Important
factors,
however,
compromise
delivery
guideline-concordant
management
osteoradionecrosis
(ORN),
including
patient
access
this
care.
This
is
directed
these
related
issues,
order
foster
enhanced
approaches
for
ORN
management.
Recent
findings
The
centered
2024
Journal
Clinical
Oncology
publication
‘Prevention
Management
Patients
With
Head
Neck
Cancer
Treated
Radiation
Therapy:
ISOO-MASCC-ASCO
Guideline’,
companion
JCO
Practice
which
clinical
insights
guideline
are
addressed.
Key
recent
literature
cited
provide
contemporary
decision-making
prevention
early
diagnosis
treatment
ORN.
Although
a
relatively
infrequent
complication
patients,
can
have
profound
financial
impact
when
it
occurs.
Summary
Interprofessional
oncology
care
essential
Future
research
needed
enhance
management,
studies
predicting
risk
development
based
on
patient-centered
factors.
Язык: Английский
New trends in supportive care of head and neck cancers
Current Opinion in Oncology,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 24, 2025
Purpose
of
review
Supportive
care
plays
a
vital
role
in
the
management
head
and
neck
cancer
(HNC)
patients,
as
disease
often
affects
frail
older
population
that
is
treated
with
multiple
strategies
associated
severe
symptoms.
We
will
focus
on
mucositis,
dermatitis,
dysphagia,
pain,
cachexia,
infections,
they
are
among
most
common
challenging
symptoms
encountered.
Recent
findings
Efforts
have
focused
multiomics
approaches
to
decipher
complex
biological
pathways
drive
symptom
onset
treatment-related
toxicities,
aim
developing
novel
therapeutic
strategies.
A
notable
example
ponsegromab,
monoclonal
antibody
designed
target
cachexia.
Other
promising
areas
research,
such
machine-learning
models
oral
gut
microbiota
cachexia
actively
being
explored;
however,
their
impact
date
remains
limited.
Summary
In
recent
years,
new
knowledge
has
emerged
regarding
underlying
causes
predictive
for
supportive
HNC
patients.
Unfortunately,
this
expanding
body
primarily
adds
complexity
without
translating
into
practical
applications
or
substantial
improvements
Future
efforts
should
prioritize
standardization
algorithms,
generation
robust
evidence
based
existing
preclinical
models.
Язык: Английский
Automated Detection of Oral Malignant Lesions Using Deep Learning: Scoping Review and Meta‐Analysis
Oral Diseases,
Год журнала:
2024,
Номер
unknown
Опубликована: Ноя. 3, 2024
ABSTRACT
Objective
Oral
diseases,
specifically
malignant
lesions,
are
serious
global
health
concerns
requiring
early
diagnosis
for
effective
treatment.
In
recent
years,
deep
learning
(DL)
has
emerged
as
a
powerful
tool
the
automated
detection
and
classification
of
oral
lesions.
This
research,
by
conducting
scoping
review
meta‐analysis,
aims
to
provide
an
overview
progress
achievements
in
field
lesions
using
DL.
Materials
Methods
A
was
conducted
identify
relevant
studies
published
last
5
years
(2018–2023).
comprehensive
search
several
electronic
databases,
including
PubMed,
Web
Science,
Scopus.
Two
reviewers
independently
assessed
eligibility
extracted
data
standardized
form,
meta‐analysis
synthesize
findings.
Results
Fourteen
utilizing
various
DL
algorithms
were
identified
included
from
clinical
images.
Among
these,
three
meta‐analysis.
The
estimated
pooled
sensitivity
specificity
0.86
(95%
confidence
interval
[CI]
=
0.80–0.91)
0.67
CI
0.58–0.75),
respectively.
Conclusions
results
indicate
that
improve
Future
research
should
develop
validated
diagnosis.
Trial
Registration
Open
Science
Framework
(
https://osf.io/4n8sm
)
Язык: Английский